Open original FDA record ↗Recall record
- FDA identifier
- Z-0269-2007
- Company in FDA record
- Guidant Corporation
- FDA classification date
- Dec 16, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Shock Effectiveness: there is a potential for malfunction of a high voltage wire, which could compromise effectiveness of shock therapy. While no energy is lost, defibrillation thresholds may be higher (and safety margin may be reduced) because the shocking vector has changed.
Source facts
- Action
- An Important Medical Device Information letter, dated 10/09/2006 was sent to physicians following patients with a potentially affected device. The letter describes the issue, provides for a projected rate of occurrence, and provides recommendations. An October 9, 2006 Product Advisory Letter, beginning October 30, 2006, was also sent to provide an update that further laboratory testing and analysis indicates that the nominal probability of malfunction is higher than their earlier prediction. Non-implanted devices have been retrieved.
- Initiated
- 2006-09-30
- Root cause
- Other
- Terminated
- 2007-04-01
- Distribution
- Worldwide distribution ---- including states of CA, FL, GA, IA, IL, KY, MA, MO, NJ, NY, OH, PA, TX and countries of Italy, Netherlands, Sweden, United Kingdom.
- Recall number
- Z-0269-2007
- Recall status
- Terminated
- CDRH record ID
- 48748
- FDA classified
- 2006-12-16
- Recall event number
- 36495